跳至主要内容
临床试验/NCT04920851
NCT04920851Unknown不适用

Comparison of Cytokine Hemadsorption as an Immunomodulator Therapy in Covid 19 Patients With and Without Bacterial Sepsis

Derince Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2021年6月10日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
23
试验地点
1
主要终点
interleukin 6

研究概览

简要总结

In this retrospective study, we aimed to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in COVID-19 ICU patients with or without sepsis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • COVID-19 patients were the available data of laboratory diagnosis of COVID-19 (a positive throat swab nucleic acid test or positive serum COVID-19 specific antibody test),
  • patients with COVID-19 induced sepsis was detection of bacterial agent in blood or tracheal culture

排除标准

  • below 18 aged
  • those who did not undergo hemoperfusion

结局指标

主要结局

interleukin 6

时间窗: 1 month

level of interleukin 6

次要结局

未报告次要终点

研究者

发起方
Derince Training and Research Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

İLKE KÜPELİ

ASSOC. PROF

Biruni University

研究点 (1)

Loading locations...

相似试验

Cytokine Hemadsorption in Covid 19 Patients With... | 临床试验